Phagelux Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Phagelux Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11334
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Phagelux Inc (Phagelux) is an anti-infectives company that provides antibacterial products and solutions. The company uses phage lysis enzymes and biological agents for the treatment of antibiotic resistant bacteria and related diseases in human beings and crops. Its product portfolio includes AgriPhage-Cmm a biological control for bacterial canker disease on tomato, AgriPhage a biological control for bacterial spot and bacterial speck on tomatoes and peppers, and Lexia to treat shrimp induced pancreatic diseases in humans. Phagelux’s pipeline products include investigational candidates and AgriPhage Xcv and Pst, fire blight, AgriPhage-Cmm, AgriPage citrus, and seed coating in crops. The company conducts research on delivery systems, phages for feeds and medicines of animals, and lysins for human uses. It operates research and development centers and manufacturing facilities in the US and China. Phagelux is headquartered in Shanghai City, China.

Phagelux Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Phagelux Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Phagelux Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Phagelux Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Phagelux Acquires Certain Assets of Scithera Microbial Technologies 10
Phagelux to Acquire Assets of Biophage Pharma 11
Phagelux Acquires Biodegradable Polymer Delivery Systems from Iveria 12
Venture Financing 13
Phagelux Raises Funds Through Venture Financing 13
OmniLytics Raises US$0.2 Million In Venture Financing 14
Partnerships 15
Phagelux Enters into Agreement with Johnson & Johnson Consumer 15
Equity Offering 16
Phagelux Raises Funds through Private Placement 16
Phagelux to Raise up to USD10 Million in Private Placement of Shares 17
Asset Transactions 18
Phagelux Acquires Certain Assets of Scithera Microbial Technologies 18
Phagelux Inc – Key Competitors 19
Phagelux Inc – Key Employees 20
Phagelux Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Phagelux Inc, Pharmaceuticals & Healthcare, Key Facts 2
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Phagelux Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Phagelux Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Phagelux Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Phagelux Acquires Certain Assets of Scithera Microbial Technologies 10
Phagelux to Acquire Assets of Biophage Pharma 11
Phagelux Acquires Biodegradable Polymer Delivery Systems from Iveria 12
Phagelux Raises Funds Through Venture Financing 13
OmniLytics Raises US$0.2 Million In Venture Financing 14
Phagelux Enters into Agreement with Johnson & Johnson Consumer 15
Phagelux Raises Funds through Private Placement 16
Phagelux to Raise up to USD10 Million in Private Placement of Shares 17
Phagelux Acquires Certain Assets of Scithera Microbial Technologies 18
Phagelux Inc, Key Competitors 19
Phagelux Inc, Key Employees 20
Phagelux Inc, Subsidiaries 21

List of Figures
Phagelux Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Phagelux Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Phagelux Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Phagelux Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Landis Taipei Hotel Co., Ltd:企業の戦略・SWOT・財務情報
    The Landis Taipei Hotel Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary The Landis Taipei Hotel Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Martinrea International Inc:企業の戦略・SWOT・財務分析
    Martinrea International Inc - Strategy, SWOT and Corporate Finance Report Summary Martinrea International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Asia Hotel Public Company Limited:企業の戦略・SWOT・財務情報
    Asia Hotel Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Asia Hotel Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • HearMeOut Limited (HMO):企業の財務・戦略的SWOT分析
    HearMeOut Limited (HMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Pedernales Electric Cooperative Inc:企業の戦略的SWOT分析
    Pedernales Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Transcontinental Inc (TCL.A):企業の財務・戦略的SWOT分析
    Transcontinental Inc (TCL.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Wawa Inc:企業の戦略・SWOT・財務分析
    Wawa Inc - Strategy, SWOT and Corporate Finance Report Summary Wawa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Concho Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Concho Resources Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Concho Resources Inc (Concho) is an oil and gas company that acquires, develops and explores oil and natural gas properties. The company owns and operates exploration assets in the Permian Basin …
  • Petro Matad Ltd (MATD):企業の財務・戦略的SWOT分析
    Summary Petro Matad Ltd (Petro Matad) is an oil and gas company that develops and operates oil and gas exploration properties. The company’s upstream oil and gas exploration asset base includes Block IV, Block XX, and Block V. Its Block XX is located in the far eastern part of Mongolia producing oil …
  • Exillon Energy Plc (EXI):石油・ガス:M&Aディール及び事業提携情報
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Myers Industries Inc (MYE):企業の財務・戦略的SWOT分析
    Summary Myers Industries Inc (Myers) is a chemical company that manufactures and distributes plastic and rubber products. The company offers plastic storage containers, rubber tire repair products, custom plastic and rubber products, tire balancers and tire retread products. It also provides materia …
  • Cypark Resources Berhad (CYPARK):企業の財務・戦略的SWOT分析
    Summary Cypark Resources Berhad (CRB) is a clean technology company that offers environmental engineering services. The company offers engineering and technology services on transforming dump sites to an economic and environmental boon. Its services include environmental remediation, integrated wast …
  • Boston Children’s Hospital:医療機器:M&Aディール及び事業提携情報
    Summary Boston Children's Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organizatio …
  • Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, …
  • H. Lee Moffitt Cancer Center & Research Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary H. Lee Moffitt Cancer Center & Research Institute Inc (Moffitt) is a healthcare service provider. It is engaged in the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. The center offers medical services such a …
  • LG Display Co Ltd:企業の戦略・SWOT・財務情報
    LG Display Co Ltd - Strategy, SWOT and Corporate Finance Report Summary LG Display Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • The Armstrong Bros. Tool Co.:企業の戦略的SWOT分析
    The Armstrong Bros. Tool Co. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Akers Biosciences Inc (AKER):企業の財務・戦略的SWOT分析
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. ABI products include BreathScan alcohol detectors, CHUBE, METRO …
  • The KEYW Holding Corporation:企業のM&A・事業提携・投資動向
    The KEYW Holding Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The KEYW Holding Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • PT Bank Permata Tbk:企業の戦略・SWOT・財務分析
    PT Bank Permata Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Permata Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆